The Biotech Growth Trust - Manager expects a reversal of recent results
The Biotech Growth Trust (BIOG) is managed by Geoff Hsu at healthcare specialist OrbiMed Capital, and benefits from OrbiMed’s presence in 11...
13 Views
The Biotech Growth Trust - Performance setback may provide an opportunity
The Biotech Growth Trust (BIOG) is managed by Geoff Hsu of OrbiMed Capital, which is a specialist healthcare investor with 11 offices across the...
1k Views
The Biotech Growth Trust - Firing on all cylinders
The Biotech Growth Trust (BIOG) is managed by Geoff Hsu, who is able to draw on the considerable resources of specialist healthcare investor...
104 Views
The Biotech Growth Trust - Positive outlook for 2020
The Biotech Growth Trust (BIOG) is managed by Geoff Hsu and Richard Klemm at OrbiMed Capital. They remain optimistic about the prospects for the...
786 Views
The Biotech Growth Trust - Positive outlook for the biotech sector
The Biotech Growth Trust (BIOG) aims to generate long-term capital growth from a concentrated portfolio of global biotech companies. It is jointly...
57 Views